These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 22486264

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.
    Keino H, Okada AA, Watanabe T, Taki W.
    Br J Ophthalmol; 2011 Sep; 95(9):1245-50. PubMed ID: 21183514
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
    Jpn J Ophthalmol; 2007 Sep; 51(3):191-6. PubMed ID: 17554481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
    Kazokoglu H, Saatçi O, Cuhadaroglu H, Eldem B.
    Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of patients with Behçet's disease in the 1980s and 1990s.
    Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, Hijikata K, Izawa Y, Hayashi K, Numaga J, Fujino Y, Masuda K, Araie M.
    Ophthalmology; 2004 Apr; 111(4):810-5. PubMed ID: 15051217
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G.
    J Rheumatol; 2004 Jul; 31(7):1362-8. PubMed ID: 15229958
    [Abstract] [Full Text] [Related]

  • 14. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S, Graziani G, Marcolongo R.
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [Abstract] [Full Text] [Related]

  • 15. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B, Sablé-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, Fain O, LeHoang P, Piette JC.
    Clin Exp Rheumatol; 2004 Sep; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [Abstract] [Full Text] [Related]

  • 16. A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Hirano T, Ohguro N, Hohki S, Hagihara K, Shima Y, Narazaki M, Ogata A, Yoshizaki K, Kumanogoh A, Kishimoto T, Tanaka T.
    Mod Rheumatol; 2012 Apr; 22(2):298-302. PubMed ID: 21748365
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.